ASX
Telix Pharmaceuticals Limited
TLX:ASX•Healthcare
Sensitive ASX Announcement
ZIRCON Ph III Renal Cancer Study to be Presented at ASCO GU
Published: 22/12/22, 08:25am (AEST)•2 pages